Health Condition 1: F323- Major depressive disorder, singleepisode, severe with psychotic features Health Condition 2: F39- Unspecified mood [affective] disorder
Conditions
Interventions
Intervention1: A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOLKETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY: Patients will receive 6-8 sessions on alterna
Sponsors
MGM MEDICAL COLLEGE AND HOSPITAL AURANGABAD
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with American society of Anaesthesiology (ASA) physical status I and II 2.Patients of both sexes between the ages of 18 and 65 years.
Exclusion criteria
Exclusion criteria: 1.Patient on chronic opiate use such as tramadol 2.Pregnant females and lactating mothers. 3.Known allergies to the study drugs 4.Patients with hypertension, IHD and heart disease 5.Contraindications to ECT such as intracranial hypertension, previous fractures, glaucoma, cerebrovascular malformation, presence of a pacemaker. 6 Patient on Beta-blockers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY Timepoint: A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY | — |
Secondary
| Measure | Time frame |
|---|---|
| A COMPARATIVE STUDY OF EFFECTIVENESS OF PROPOFOL, KETOFOL AND KETOFOL WITH DEXMEDETOMIDINE AS INDUCTION AGENT FOR ELECTROCONVULSIVE THERAPY Timepoint: 1.Incidence and severity of post ECT agitation 2.Incidence and severity of post ECT myalgia | — |
Countries
India
Contacts
Public ContactDr v m sasturkar
mgm aurangabad
Outcome results
None listed